Investor Johnson & Johnson
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Johnson & Johnson . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2024-11-01 13G/A CVRX / CVRx, Inc. 4,109,336 4,103,430
2024-10-18 13G RAPP / Rapport Therapeutics, Inc. 2,498,051
2024-10-18 13G/A MGTX / MeiraGTx Holdings plc 6,641,064 6,641,064
2024-07-30 13G RLYB / Rallybio Corporation 3,636,363
2024-05-20 13G/A KVUE / Kenvue Inc. 182,329,550
2024-04-10 13G CTNM / Contineum Therapeutics, Inc. 1,979,173
2024-02-02 13G/A PHGE / BiomX Inc. 2,113,402
2024-02-02 13G/A CVRX / CVRx, Inc. 4,109,573 4,109,336
2024-02-02 13G/A NBTX / Nanobiotix S.A. - Depositary Receipt (Common Stock) 5,623,816
2024-01-24 13G KVUE / Kenvue Inc. 182,329,550
2023-01-27 13G/A FUSN / Fusion Pharmaceuticals Inc. 3,670,516
2023-01-11 13G/A PTGX / Protagonist Therapeutics, Inc. 2,449,183 2,449,183
2022-11-14 13G/A MGTX / MeiraGTx Holdings plc 2,898,550 6,641,064
2022-02-07 13G CVRX / CVRx, Inc. 4,109,573
2022-02-01 13G/A PHAS / PhaseBio Pharmaceuticals Inc 1,607,044 1,607,044
2021-02-02 13G/A PTGX / Protagonist Therapeutics, Inc. 2,449,183 2,449,183
2021-02-02 13G/A PTGX / Protagonist Therapeutics, Inc. 2,449,183 2,449,183
2020-01-17 13G/A PRVB / Provention Bio Inc 2,400,000 1,124,973
2020-01-17 13G/A PHAS / PhaseBio Pharmaceuticals Inc 1,616,863 1,607,044
2019-11-26 13G CHAC.WS / Chardan Healthcare Acquisition Corp. 2,133,402
2019-03-04 13G MGTX / MeiraGTx Holdings plc 2,898,550
2019-01-22 13G PRVB / Provention Bio Inc 2,400,000
2019-01-22 13G PHAS / PhaseBio Pharmaceuticals Inc 1,616,863
2019-01-22 13G/A KDNY / Chinook Therapeutics Inc 3,906,207 3,906,207
2019-01-22 13G/A MGNX / MacroGenics, Inc. 1,923,077
2019-01-22 13G/A MRUS / Merus N.V. 1,195,943
2019-01-22 13G/A GID / GI DYNAMICS, INC. 565,569
2019-01-22 13G/A ALDX / Aldeyra Therapeutics, Inc. 1,050,292
2018-01-22 13G/A CBIO / Crescent Biopharma, Inc. 1,029,144 91,826
2018-01-22 13G/A TCON / TRACON Pharmaceuticals, Inc. 840,022 840,022
2017-11-22 13G/A US00448Q2012 / Achillion Pharmaceuticals, Inc. 18,367,346
2017-09-14 13G/A NERV / Minerva Neurosciences, Inc. 3,892,256
2017-01-18 13G MRUS / Merus N.V. 1,195,943
2017-01-18 13G/A NVRO / Nevro Corp. 2,066,740 1,400,824
2016-10-31 13G TCON / TRACON Pharmaceuticals, Inc. 840,022
2016-08-19 13G PTGX / Protagonist Therapeutics, Inc. 2,449,183
2016-02-12 13G/A NERV / Minerva Neurosciences, Inc. 3,892,256
2016-02-12 13G/A GNCA / Genocea Biosciences Inc 1,330,305
2016-02-12 13G/A NVRO / Nevro Corp. 2,066,740
2016-02-12 13G/A NLTX / Neoleukin Therapeutics, Inc. 0
2016-02-12 13G KDNY / Chinook Therapeutics Inc 3,906,207
2015-08-28 13G CBIO / Crescent Biopharma, Inc. 1,029,144
2015-07-07 13G US00448Q2012 / Achillion Pharmaceuticals, Inc. 18,367,346
2015-02-06 13G NLTX / Neoleukin Therapeutics, Inc. 1,614,821
2015-02-06 13G GID / GI DYNAMICS, INC. 5,655,692
2015-02-05 13G MGNX / MacroGenics, Inc. 1,923,077
2015-02-05 13G GNCA / Genocea Biosciences Inc 1,431,520
2015-02-05 13G ALDX / Aldeyra Therapeutics, Inc. 1,750,292
2015-02-05 13G NVRO / Nevro Corp. 3,077,005
2014-07-17 13G NERV / Minerva Neurosciences, Inc. 3,284,353
2013-10-10 13G/A PRTA / Prothena Corporation plc 209,421
2013-04-19 13G/A ELN / Elan Corp. Plc 25,382,575
2013-02-13 13G PRTA / Prothena Corporation plc 2,619,421
2013-02-12 13G/A UBI / UNIVERSAL BIOSENSORS INC
2012-01-25 13G/A TNGNQ / Tengion, Inc.
2012-01-25 13G/A UBI / UNIVERSAL BIOSENSORS INC 14,915,400
2012-01-24 13G/A APEN / Apollo Endosurgery Inc